UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 32

Sortiert nach

Diagnostic Criteria, Classification, and Nomenclature for Painful Bladder Syndrome/Interstitial Cystitis: An ESSIC Proposal

European urology, 2008-01, Vol.53 (1), p.60-67

2008

Volltextzugriff (PDF)

Correction: Interaction between c-jun and Androgen Receptor Determines the Outcome of Taxane Therapy in Castration Resistant Prostate Cancer

PloS one, 2018-12, Vol.13 (12), p.e0209544-e0209544

2018

Volltextzugriff (PDF)

Serotonin activates MAP kinase and PI3K/Akt signaling pathways in prostate cancer cell lines

Urologic oncology, 2011-07, Vol.29 (4), p.436-445

2011

Volltextzugriff (PDF)

Multiple Cellular Mechanisms Related to Cyclin A1 in Prostate Cancer Invasion and Metastasis

JNCI : Journal of the National Cancer Institute, 2008-07, Vol.100 (14), p.1022-1036

2008

Volltextzugriff (PDF)

Interaction between c-jun and androgen receptor determines the outcome of taxane therapy in castration resistant prostate cancer

PloS one, 2013-11, Vol.8 (11), p.e79573-e79573

2013

Volltextzugriff (PDF)

DD3 RNA Analysis in Urine ? A New Perspective for Detecting Prostate Cancer

European urology, 2004-08, Vol.46 (2), p.182-187

2004

Volltextzugriff (PDF)

Expression and localization of serotonin receptors in human breast cancer

Anticancer research, 2013-02, Vol.33 (2), p.363-370

2013

Volltextzugriff (PDF)

Clinical Utility of the PCA3 Urine Assay in European Men Scheduled for Repeat Biopsy

European urology, 2008-11, Vol.54 (5), p.1081-1088

2008

Volltextzugriff (PDF)

Abstract B15: Androgen receptor recruitment to c-Jun promoter region regulates chemosensitivity of prostate cancer cells to taxane therapy

Molecular cancer therapeutics, 2015-12, Vol.14 (12_Supplement_2), p.B15-B15

2015

Volltextzugriff (PDF)

Properties and effects of a novel liquid crystal nanoparticle formulation of docetaxel in a prostate cancer mouse model

European journal of pharmaceutical sciences, 2010-10, Vol.41 (2), p.369-375

2010

Volltextzugriff (PDF)

Reducing recurrence in non-muscle-invasive bladder cancer by systematically implementing guideline-based recommendations: effect of a prospective intervention in primary bladder cancer patients

Scandinavian journal of urology, 2019-05, Vol.53 (2-3), p.109-115

2019

Volltextzugriff (PDF)

Corrigendum to “Properties and effects of a novel liquid crystal nanoparticle formulation of docetaxel in a prostate cancer mouse model” [Eur. J. Pharm. Sci. 41 (2) (2010) 369–375]

European journal of pharmaceutical sciences, 2014-10, Vol.63, p.243-243

2014

Volltextzugriff (PDF)

Abstract C226: Phosphorylation of ser63/73 in c-jun is required to respond to docetaxel treatment in prostate cancer cells

Molecular cancer therapeutics, 2013-11, Vol.12 (11_Supplement), p.C226-C226

2013

Volltextzugriff (PDF)

1094: Diagnosis of Early Prostate Cancer Using DD3PCA3MRNA Expression in Urine

The Journal of urology, 2004-04, Vol.171 (4), p.288-288

2004

Volltextzugriff (PDF)

OVEREXPRESSION OF PHOSPHORYLATED C-JUN IN PROSTATE CANCER CELLS INTERFERES WITH DOCETAXEL RESISTANT THERAPY IN IN VIVO MODEL

The Journal of urology, 2009, Vol.181 (4), p.261-261

2009

Volltextzugriff (PDF)

Age, prostate-specific antigen, and digital rectal examination as determinants of the probability of having prostate cancer

Urology (Ridgewood, N.J.), 2001-06, Vol.57 (6), p.1100-1104

2001

Volltextzugriff (PDF)

DD3PCA3 RNA analysis in urine--a new perspective for detecting prostate cancer

European urology, 2004-08, Vol.46 (2), p.182-6; discussion 187

2004

Volltextzugriff (PDF)

DD3PCA3 RNA analysis in urine: A new perspective for detecting prostate cancer. Commentary

European urology, 2004, Vol.46 (2), p.182-187

2004

Volltextzugriff (PDF)

DD3 PCA3 RNA Analysis in Urine – A New Perspective for Detecting Prostate Cancer

European urology, 2004, Vol.46 (2), p.182-187

2004

Volltextzugriff (PDF)

MULTIPLE CELLULAR MECHANISMS IN PROSTATE CANCER INVASION AND METASTASIS

Anticancer research, 2008, Vol.28 (5C), p.528

2008

Volltextzugriff (PDF)

PROSTATE CANCER 3 (PCA3) REPRESENTS A CLINICALLY MEANINGFUL PREDICTOR OF PROSTATE CANCER AT REPEAT BIOPSY

The Journal of urology, 2008, Vol.179 (4), p.724-725

2008

Volltextzugriff (PDF)

PERFORMANCE ANALYSIS OF DIFFERENT PCA3 CUT-OFFS

The Journal of urology, 2008, Vol.179 (4), p.705-705

2008

Volltextzugriff (PDF)

THE PROBABILITY OF HAVING PROSTATE CANCER GIVEN AGE, SERUM PSA, AND DRE AS DETERMINED FROM THE TYROL SCREENING PROJECT

The Journal of urology, 1999-04, p.290

1999

Volltextzugriff (PDF)

Urinary Markers for Detecting Bladder Cancer

EAU update series : official journal of the European Association of Urology, 2003, Vol.1 (2), p.64-70

2003

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(29)
Tagungsberichte
(3)

Sprache

Englisch
(32)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Diagnostic Criteria, Classification, and Nomenclature for Painful Bladder Syndrome/Interstitial Cystitis: An ESSIC Proposal

Correction: Interaction between c-jun and Androgen Receptor Determines the Outcome of Taxane Therapy in Castration Resistant Prostate Cancer

Serotonin activates MAP kinase and PI3K/Akt signaling pathways in prostate cancer cell lines

Multiple Cellular Mechanisms Related to Cyclin A1 in Prostate Cancer Invasion and Metastasis

Interaction between c-jun and androgen receptor determines the outcome of taxane therapy in castration resistant prostate cancer

DD3 RNA Analysis in Urine ? A New Perspective for Detecting Prostate Cancer

Expression and localization of serotonin receptors in human breast cancer

Clinical Utility of the PCA3 Urine Assay in European Men Scheduled for Repeat Biopsy

Abstract B15: Androgen receptor recruitment to c-Jun promoter region regulates chemosensitivity of prostate cancer cells to taxane therapy

Properties and effects of a novel liquid crystal nanoparticle formulation of docetaxel in a prostate cancer mouse model

Reducing recurrence in non-muscle-invasive bladder cancer by systematically implementing guideline-based recommendations: effect of a prospective intervention in primary bladder cancer patients

Corrigendum to “Properties and effects of a novel liquid crystal nanoparticle formulation of docetaxel in a prostate cancer mouse model” [Eur. J. Pharm. Sci. 41 (2) (2010) 369–375]

Abstract C226: Phosphorylation of ser63/73 in c-jun is required to respond to docetaxel treatment in prostate cancer cells

The prostate cancer gene 3 (PCA3) urine test in men with previous negative biopsies: does free‐to‐total prostate‐specific antigen ratio influence the performance of the PCA3 score in predicting positive biopsies?

1094: Diagnosis of Early Prostate Cancer Using DD3PCA3MRNA Expression in Urine

OVEREXPRESSION OF PHOSPHORYLATED C-JUN IN PROSTATE CANCER CELLS INTERFERES WITH DOCETAXEL RESISTANT THERAPY IN IN VIVO MODEL

Age, prostate-specific antigen, and digital rectal examination as determinants of the probability of having prostate cancer

DD3PCA3 RNA analysis in urine--a new perspective for detecting prostate cancer

DD3PCA3 RNA analysis in urine: A new perspective for detecting prostate cancer. Commentary

DD3 PCA3 RNA Analysis in Urine – A New Perspective for Detecting Prostate Cancer

MULTIPLE CELLULAR MECHANISMS IN PROSTATE CANCER INVASION AND METASTASIS

PROSTATE CANCER 3 (PCA3) REPRESENTS A CLINICALLY MEANINGFUL PREDICTOR OF PROSTATE CANCER AT REPEAT BIOPSY

PERFORMANCE ANALYSIS OF DIFFERENT PCA3 CUT-OFFS

THE PROBABILITY OF HAVING PROSTATE CANCER GIVEN AGE, SERUM PSA, AND DRE AS DETERMINED FROM THE TYROL SCREENING PROJECT

Urinary Markers for Detecting Bladder Cancer

Suchergebnisse filtern